Several bioinformatics analyses further demonstrated that ACE2 expression is elevated in both lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) subtypes of NSCLC compared to normal lung tissues (12), with particularly high levels in LUAD (13). The gene discussed is ACE2; the disease is non-small cell lung carcinoma.